Atomistry » Fluorine » PDB 5ddf-5dy7 » 5dg5
Atomistry »
  Fluorine »
    PDB 5ddf-5dy7 »
      5dg5 »

Fluorine in PDB 5dg5: Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157

Enzymatic activity of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157

All present enzymatic activity of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157:
2.7.10.1;

Protein crystallography data

The structure of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157, PDB code: 5dg5 was solved by B.D.Smith, M.D.Kaufman, C.B.Leary, B.A.Turner, S.A.Wise, Y.M.Ahn, R.J.Booth, T.M.Caldwell, C.L.Ensinger, M.M.Hood, W.-P.Lu, T.W.Patt, W.C.Patt, T.J.Rutkoski, T.Samarakoon, H.Telikepalli, L.Vogeti, S.Vogeti, K.M.Yates, L.Chun, L.J.Stewart, M.Clare, D.L.Flynn, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 19.65 / 2.60
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 37.130, 115.880, 90.160, 90.00, 92.92, 90.00
R / Rfree (%) 20.4 / 24.5

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 (pdb code 5dg5). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157, PDB code: 5dg5:
Jump to Fluorine binding site number: 1; 2; 3; 4; 5; 6;

Fluorine binding site 1 out of 6 in 5dg5

Go back to Fluorine Binding Sites List in 5dg5
Fluorine binding site 1 out of 6 in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1401

b:37.6
occ:1.00
 F37 A:5B41401 0.0 37.6 1.0
C34 A:5B41401 1.4 36.6 1.0
C35 A:5B41401 2.4 36.9 1.0
C33 A:5B41401 2.4 34.8 1.0
CD1 A:LEU1195 3.4 35.8 1.0
CG1 A:VAL1139 3.5 27.9 1.0
CD2 A:LEU1195 3.6 34.7 1.0
C36 A:5B41401 3.6 37.1 1.0
C32 A:5B41401 3.6 34.9 1.0
CE2 A:PHE1134 3.8 35.2 1.0
CD2 A:PHE1134 3.9 35.4 1.0
CG A:LEU1195 4.1 34.2 1.0
C31 A:5B41401 4.1 35.2 1.0
O A:VAL1220 4.3 25.3 1.0
CE2 A:PHE1200 4.4 37.6 1.0
CB A:VAL1139 4.6 28.0 1.0
CG1 A:VAL1220 4.6 27.1 1.0
CG2 A:VAL1139 4.7 29.2 1.0
C A:VAL1220 4.7 26.6 1.0
CD2 A:HIS1202 4.8 44.1 1.0
CD2 A:PHE1200 4.8 37.7 1.0
CZ A:PHE1200 4.9 38.0 1.0
CZ A:PHE1134 4.9 34.6 1.0
CA A:ALA1221 4.9 29.2 1.0
CG A:PHE1134 5.0 36.5 1.0

Fluorine binding site 2 out of 6 in 5dg5

Go back to Fluorine Binding Sites List in 5dg5
Fluorine binding site 2 out of 6 in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1401

b:33.1
occ:1.00
 F7 A:5B41401 0.0 33.1 1.0
C1 A:5B41401 1.3 31.5 1.0
C2 A:5B41401 2.3 31.9 1.0
C6 A:5B41401 2.4 32.0 1.0
O9 A:5B41401 2.7 32.4 1.0
CG1 A:VAL1092 3.3 33.8 1.0
CG2 A:VAL1092 3.6 35.7 1.0
C3 A:5B41401 3.6 31.7 1.0
C5 A:5B41401 3.6 31.2 1.0
CB A:LYS1110 3.7 32.5 1.0
CD1 A:LEU1157 3.7 33.3 1.0
CE1 A:PHE1223 3.9 34.4 1.0
C10 A:5B41401 3.9 32.9 1.0
CD A:LYS1110 4.0 36.5 1.0
CB A:VAL1092 4.0 34.8 1.0
C4 A:5B41401 4.1 31.2 1.0
CG A:LYS1110 4.2 35.0 1.0
CD1 A:PHE1223 4.3 34.0 1.0
C15 A:5B41401 4.5 31.9 1.0
O24 A:5B41401 4.5 32.7 1.0
CA A:LYS1110 4.6 30.6 1.0
N22 A:5B41401 4.8 31.6 1.0
CZ A:PHE1223 4.9 35.7 1.0
N A:LYS1110 4.9 28.2 1.0
CB A:ALA1108 4.9 30.9 1.0
C11 A:5B41401 4.9 32.7 1.0

Fluorine binding site 3 out of 6 in 5dg5

Go back to Fluorine Binding Sites List in 5dg5
Fluorine binding site 3 out of 6 in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1401

b:32.9
occ:1.00
 F8 A:5B41401 0.0 32.9 1.0
C4 A:5B41401 1.3 31.2 1.0
C3 A:5B41401 2.4 31.7 1.0
C5 A:5B41401 2.4 31.2 1.0
N22 A:5B41401 2.7 31.6 1.0
CD2 A:LEU1140 3.1 28.9 1.0
CB A:ALA1221 3.2 29.9 1.0
O27 A:5B41401 3.5 37.5 1.0
C2 A:5B41401 3.6 31.9 1.0
C6 A:5B41401 3.7 32.0 1.0
CB A:PHE1223 3.7 33.4 1.0
CA A:PHE1223 3.8 33.3 1.0
N A:PHE1223 3.9 35.2 1.0
C23 A:5B41401 4.1 32.2 1.0
CG A:PHE1223 4.1 33.5 1.0
C1 A:5B41401 4.1 31.5 1.0
CD1 A:PHE1223 4.3 34.0 1.0
CG A:MET1211 4.3 36.4 1.0
N A:ASP1222 4.3 34.1 1.0
CA A:ALA1221 4.4 29.2 1.0
SD A:MET1211 4.5 40.3 1.0
C A:ASP1222 4.5 36.6 1.0
C26 A:5B41401 4.5 34.4 1.0
CG A:LEU1140 4.5 29.1 1.0
C A:ALA1221 4.8 31.4 1.0
O9 A:5B41401 4.8 32.4 1.0
C25 A:5B41401 4.9 33.8 1.0
O24 A:5B41401 4.9 32.7 1.0
CD2 A:PHE1223 4.9 34.5 1.0
CB A:LEU1140 4.9 28.8 1.0
CD1 A:LEU1157 5.0 33.3 1.0

Fluorine binding site 4 out of 6 in 5dg5

Go back to Fluorine Binding Sites List in 5dg5
Fluorine binding site 4 out of 6 in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 4 of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F1401

b:40.2
occ:1.00
 F37 B:5B41401 0.0 40.2 1.0
C34 B:5B41401 1.3 35.6 1.0
C33 B:5B41401 2.4 33.5 1.0
C35 B:5B41401 2.4 36.5 1.0
CD1 B:LEU1195 3.4 30.9 1.0
CG1 B:VAL1139 3.4 25.9 1.0
C32 B:5B41401 3.6 34.7 1.0
C36 B:5B41401 3.6 35.6 1.0
CD2 B:LEU1195 3.6 32.9 1.0
CE2 B:PHE1134 3.9 36.1 1.0
CD2 B:PHE1134 4.0 36.0 1.0
CG B:LEU1195 4.1 31.5 1.0
C31 B:5B41401 4.1 34.3 1.0
O B:VAL1220 4.2 23.6 1.0
CE2 B:PHE1200 4.4 38.1 1.0
CG1 B:VAL1220 4.5 24.1 1.0
CB B:VAL1139 4.6 26.3 1.0
C B:VAL1220 4.6 25.2 1.0
CG2 B:VAL1139 4.6 25.9 1.0
CD2 B:HIS1202 4.8 35.0 1.0
CA B:ALA1221 4.8 28.4 1.0
N B:ALA1221 4.9 26.4 1.0
CD2 B:PHE1200 4.9 37.7 1.0
CB B:VAL1220 4.9 24.4 1.0
CZ B:PHE1200 5.0 36.0 1.0

Fluorine binding site 5 out of 6 in 5dg5

Go back to Fluorine Binding Sites List in 5dg5
Fluorine binding site 5 out of 6 in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 5 of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F1401

b:32.2
occ:1.00
 F7 B:5B41401 0.0 32.2 1.0
C1 B:5B41401 1.3 31.4 1.0
C2 B:5B41401 2.4 31.3 1.0
C6 B:5B41401 2.4 30.5 1.0
O9 B:5B41401 2.7 31.3 1.0
CG1 B:VAL1092 3.3 41.2 1.0
CD1 B:LEU1157 3.6 36.5 1.0
C3 B:5B41401 3.6 30.4 1.0
C5 B:5B41401 3.6 30.8 1.0
CG2 B:VAL1092 3.6 40.8 1.0
CB B:LYS1110 3.7 36.9 1.0
C10 B:5B41401 3.9 30.8 1.0
CE1 B:PHE1223 4.0 34.6 1.0
CD B:LYS1110 4.1 38.8 1.0
CB B:VAL1092 4.1 41.2 1.0
C4 B:5B41401 4.1 30.4 1.0
CG B:LYS1110 4.3 37.0 1.0
CD1 B:PHE1223 4.3 34.8 1.0
C15 B:5B41401 4.4 29.6 1.0
CA B:LYS1110 4.5 36.3 1.0
O24 B:5B41401 4.6 32.0 1.0
N B:LYS1110 4.8 34.1 1.0
CB B:ALA1108 4.8 34.6 1.0
N22 B:5B41401 4.8 32.3 1.0
CZ B:PHE1223 4.9 34.3 1.0
C11 B:5B41401 5.0 30.4 1.0

Fluorine binding site 6 out of 6 in 5dg5

Go back to Fluorine Binding Sites List in 5dg5
Fluorine binding site 6 out of 6 in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 6 of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F1401

b:30.9
occ:1.00
 F8 B:5B41401 0.0 30.9 1.0
C4 B:5B41401 1.3 30.4 1.0
C3 B:5B41401 2.4 30.4 1.0
C5 B:5B41401 2.4 30.8 1.0
N22 B:5B41401 2.7 32.3 1.0
CB B:ALA1221 3.2 29.4 1.0
CD2 B:LEU1140 3.3 30.3 1.0
CB B:PHE1223 3.5 34.3 1.0
O27 B:5B41401 3.5 33.0 1.0
CA B:PHE1223 3.6 33.8 1.0
C2 B:5B41401 3.6 31.3 1.0
C6 B:5B41401 3.7 30.5 1.0
N B:PHE1223 3.7 35.7 1.0
CG B:PHE1223 4.0 35.3 1.0
C23 B:5B41401 4.1 32.8 1.0
C1 B:5B41401 4.1 31.4 1.0
CD1 B:PHE1223 4.2 34.8 1.0
N B:ASP1222 4.2 31.8 1.0
CG B:MET1211 4.4 34.4 1.0
C B:ASP1222 4.4 34.7 1.0
CA B:ALA1221 4.4 28.4 1.0
SD B:MET1211 4.4 36.7 1.0
C26 B:5B41401 4.5 33.5 1.0
C B:ALA1221 4.7 29.4 1.0
CG B:LEU1140 4.7 29.3 1.0
O9 B:5B41401 4.8 31.3 1.0
CD2 B:PHE1223 4.8 34.4 1.0
C25 B:5B41401 4.8 33.4 1.0
O B:ASP1222 4.9 36.5 1.0
O24 B:5B41401 4.9 32.0 1.0
CA B:ASP1222 5.0 34.6 1.0

Reference:

B.D.Smith, M.D.Kaufman, C.B.Leary, B.A.Turner, S.C.Wise, Y.M.Ahn, R.J.Booth, T.M.Caldwell, C.L.Ensinger, M.M.Hood, W.P.Lu, T.W.Patt, W.C.Patt, T.J.Rutkoski, T.Samarakoon, H.Telikepalli, L.Vogeti, S.Vogeti, K.M.Yates, L.Chun, L.J.Stewart, M.Clare, D.L.Flynn. Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance Via Balanced Inhibition of Met, TIE2, and VEGFR2. Mol.Cancer Ther. V. 14 2023 2015.
ISSN: ESSN 1538-8514
PubMed: 26285778
DOI: 10.1158/1535-7163.MCT-14-1105
Page generated: Tue Jul 15 03:00:53 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy